Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma

BACKGROUND: Gliomas account for more than 60 % of all primary central nervous system neoplasms. Low-grade gliomas display a tendency to progress to more malignant phenotypes and the most frequent and malignant gliomas are glioblastomas (GBM). Another type of glioma, oligodendroglioma originates from...

Descripción completa

Detalles Bibliográficos
Autores principales: Gimenez, Marcela, Marie, Suely Kazue Nagahashi, Oba-Shinjo, Sueli, Uno, Miyuki, Izumi, Clarice, Oliveira, João Bosco, Rosa, Jose Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502388/
https://www.ncbi.nlm.nih.gov/pubmed/26108672
http://dx.doi.org/10.1186/s12885-015-1473-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502388/
https://www.ncbi.nlm.nih.gov/pubmed/26108672
http://dx.doi.org/10.1186/s12885-015-1473-9

Ejemplares similares